BG
NEUE

Bellevue Group’s NeueHealth NEUE Stock Holding History

Bellevue Group’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,750
Closed -$12.2M – 233
2021
Q3 		$12.2M Hold
18,750
– – 0.12% 112
2021
Q2 		$25.7M Buy
+18,750
New +$25.7M 0.25% 99

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

Bellevue Group's NEUE Position: Q4 2021 in Review

Bellevue Group sold out of NeueHealth (NEUE) in Q4 2021, closing a stake of 18,750 shares — an estimated $12.2M sold.

Bellevue Group first reported a position in NEUE in Q2 2021 and held it in 2 quarters. The position peaked at $25.7M in Q2 2021. 117 funds tracked by Wall St. Rank hold NEUE as of Q4 2021.

  • Bellevue Group reported no remaining NeueHealth position as of Q4 2021 after selling out during the quarter.
  • Bellevue Group sold 18,750 NeueHealth shares in Q4 2021, an estimated $12.2M.
  • Bellevue Group first reported a position in NeueHealth in Q2 2021 and held it in 2 quarters.
  • Bellevue Group's NeueHealth position peaked at $25.7M in Q2 2021.
  • 117 funds tracked by Wall St. Rank held NeueHealth as of Q4 2021.

Based on Bellevue Group's 13F filing for Q4 2021, filed 10 Feb 2022.